Zydus Lifesciences’ ZyVac TCV receives WHO prequalification, eligible for U.N. procurement, combating typhoid fever in high-risk regions Zydus Lifesciences’ ZyVac TCV receives WHO prequalification, eligible for U.N. procurement, combating typhoid fever in high-risk regions Industry Health News, Wellbeing Tips, Diseases, Treatment and Nutrition | The Hindu
Zydus Lifesciences gets WHO prequalification for Typhoid Vi conjugate vaccine
